Metoprolol is marketed in Australia as Betaloc, Etocar and Metrol, among others.
Curated subset. The full adverse-effect list is in the TGA Product Information; click any citation above to open it.
“Metoprolol, the active substance of METOPROLOL-WGR, is a relatively cardioselective beta-blocker, i.e. it acts on beta1-receptors mainly located in the heart at lower doses than those needed to influence the beta2-receptors mainly located in the bronchi and peripheral vessels.”
“The elimination half-life of metoprolol is between 3 and 5 hours.”
The oxidative metabolism of metoprolol is under genetic control with a major contribution of the polymorphic cytochrome P450 isoform 2D6 (CYP2D6).
Metoprolol is marketed in Australia as Betaloc, Etocar and Metrol, among others.
17 brand names are recorded against this substance from the TGA eBS Product Information repository. The full list is in the Also known as card.